PharmaVOICE Blog Post

The 5 most common mistakes in Spirometry collection

Posted By: Dan Limbach
October 25, 2016

Spirometry data is pivotal to assessing primary or secondary outcomes in most respiratory trials. A significant portion of spirometry data is of inadequate or questionable quality which can lead to increased data variability, undermine the validity of the results of a trial, and necessitate increasing the number of subjects in a trial.

View the infographic now

PAREXEL combines proven study design and oversight capabilities, with the flexibility that respiratory studies demand. We understand the importance of every breath. Whether spirometry is a primary, secondary or safety endpoint for your study, we ease the burden on patients and sites, and instill quality oversight at every step.

About the Blog Poster: Dan Limbach

Comments are closed.